The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Lundgren Johanna) > (2020-2024) > The prognostic impa...

The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types

Micke, Patrick (författare): Uppsala University,Uppsala universitet,Klinisk och experimentell patologi,Patrick Micke,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Strell, Carina (författare): Uppsala University,Uppsala universitet,Klinisk och experimentell patologi,Patrick Micke,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Mattsson, Johanna Sofia Margareta, 1985- (författare): Uppsala University,Uppsala universitet,Klinisk och experimentell patologi,Patrick Micke,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

visa fler...

Martin-Bernabe, Alfonso (författare): Karolinska Institutet,Karolinska Institute,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.,Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Brunnström, Hans (författare): Lund University,Lunds universitet,Förbättrad diagnostik och prognostik vid lungcancer och metastaser till lunga,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Improved diagnostics and prognostics of lung cancer and metastases to the lungs,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Department of Clinical Sciences Lund, Division of Pathology, Lund University, Lund, Sweden; Department of Genetics and Pathology, Division of Laboratory Medicine, Region Skåne, Lund, Sweden,Lund Univ, Dept Clin Sci Lund, Div Pathol, Lund, Sweden.;Dept Genet & Pathol, Div Lab Med, Lund, Sweden.

Huvila, Jutta (författare): Univ British Columbia, Dept Pathol, Vancouver, BC, Canada.;Univ Turku, Dept Pathol, Turku, Finland.,Department of Pathology, University of British Columbia, Vancouver, Canada; Department of Pathology, University of Turku, Turku, Finland,University of Turku

Sund, Malin (författare): Umeå universitet,Umeå University,Umeå Univ, Dept Surg & Perioperat Sci Surg, Umeå, Sweden.,Enheten för biobanksforskning,Kirurgi

Wärnberg, Fredrik (författare): Sahlgrenska Univ Hosp Göteborg, Inst Clin Sci, Dept Surg, Gothenburg, Sweden.,Department of Surgery at Institute of Clinical Sciences, Sahlgrenska University Hospital Göteborg, Göteborg, Sweden

Ponten, Fredrik (författare): Uppsala University,Uppsala universitet,Klinisk och experimentell patologi,Fredrik Pontén,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Glimelius, Bengt (författare): Uppsala University,Uppsala universitet,Experimentell och klinisk onkologi,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Hrynchyk, Ina (författare): City Clin Pathologoanat Bur, Minsk, BELARUS.,City Clinical Pathologoanatomic Bureau, Minsk, Belarus

Mauchanski, Siarhei (författare): NN Alexandrov Natl Canc Ctr Belarus, Minsk 223040, BELARUS.,N.N. Alexandrov Research Institute of Oncology and Medical Radiology,N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus

Khelashvili, Salome (författare): NN Alexandrov Natl Canc Ctr Belarus, Minsk 223040, BELARUS.,N.N. Alexandrov Research Institute of Oncology and Medical Radiology,N.N. Alexandrov National Cancer Centre of Belarus, Minsk, Belarus

Garcia-Vicien, Gemma (författare): Catalan Inst Oncol, Program Canc Therapeut Resistance, IDIBELL,ProCURE, Mol Mech & Expt Therapy Oncol Program ONCOBELL, Barcelona, Spain.,Bellvitge Biomedical Research Institute,ProCURE, Program Against Cancer therapeutic Resistance, Catalan Institute of Oncology, Molecular Mechanisms and Experimental Therapy in Oncology Program (ONCOBELL), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain

Mollevi, David G. (författare): Catalan Inst Oncol, Program Canc Therapeut Resistance, IDIBELL,ProCURE, Mol Mech & Expt Therapy Oncol Program ONCOBELL, Barcelona, Spain.,ProCURE, Program Against Cancer therapeutic Resistance, Catalan Institute of Oncology, Molecular Mechanisms and Experimental Therapy in Oncology Program (ONCOBELL), IDIBELL, L'Hospitalet de Llobregat, Catalonia, Barcelona, Spain,Bellvitge Biomedical Research Institute

Edqvist, Per-Henrik D (författare): Karolinska Institutet,Uppsala University,Uppsala universitet,Experimentell och klinisk onkologi,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Reilly, Aine O. (författare): Karolinska Institute,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.,Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Corvigno, Sara (författare): Uppsala University,Uppsala universitet,Institutionen för immunologi, genetik och patologi,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.,Karolinska University Hospital,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Dahlstrand, Hanna (författare): Uppsala University,Karolinska Institute,Uppsala universitet,Experimentell och klinisk onkologi,Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden

Botling, Johan (författare): Uppsala University,Uppsala universitet,Klinisk och experimentell patologi,Johan Botling,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Segersten, Ulrika (författare): Uppsala University,Uppsala universitet,Urologkirurgi,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Krzyzanowska, Agnieszka (författare): Lund University,Lunds universitet,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Urological cancer, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Dept Translat Med, Div Urol Canc, Lund, Sweden.,Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden

Bjartell, Anders (författare): Lund University,Lunds universitet,Urologisk cancerforskning, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Urological cancer, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Dept Translat Med, Div Urol Canc, Lund, Sweden.,Department of Translational Medicine, Division of Urological Cancers, Lund University, Lund, Sweden

Elebro, Jacob (författare): Lund University,Lunds universitet,Terapeutisk patologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Therapeutic pathology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund Univ, Dept Clin Sci Lund, Div Oncol & Therapeut Pathol, SE-22100 Lund, Sweden.,Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden

Heby, Margareta (författare): Lund University,Lunds universitet,Terapeutisk patologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Therapeutic pathology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Dept Clin Sci Lund, Div Oncol & Therapeut Pathol, SE-22100 Lund, Sweden.,Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden

Lundgren, Sebastian (författare): Lund University,Lunds universitet,Terapeutisk patologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Therapeutic pathology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Dept Clin Sci Lund, Div Oncol & Therapeut Pathol, SE-22100 Lund, Sweden.,Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden

Hedner, Charlotta (författare): Lund University,Lunds universitet,Terapeutisk patologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Therapeutic pathology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Dept Clin Sci Lund, Div Oncol & Therapeut Pathol, SE-22100 Lund, Sweden.,Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden

Borg, David (författare): Lund University,Lunds universitet,Terapeutisk patologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Therapeutic pathology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Dept Clin Sci Lund, Div Oncol & Therapeut Pathol, SE-22100 Lund, Sweden.,Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden

Brändstedt, Jenny (författare): Lund University,Lunds universitet,Kirurgi,Forskargrupper vid Lunds universitet,Surgery,Lund University Research Groups,Lund Univ, Dept Clin Sci Lund, Div Oncol & Therapeut Pathol, SE-22100 Lund, Sweden.,Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden

Sartor, Hanna (författare): Lund University,Lunds universitet,Diagnostisk radiologi, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Radiology Diagnostics, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Diagnostic Radiology, Department of Translational Medicine, Lund University, Skåne University Hospital, Lund, Sweden,Lund Univ, Skane Univ Hosp, Dept Translat Med, Diagnost Radiol, Lund, Sweden.

Malmström, Per-Uno (författare): Uppsala University,Uppsala universitet,Urologkirurgi,Department of Surgical Sciences, Uppsala University, Uppsala, Sweden

Johansson, Martin (författare): Sahlgrenska Univ Hosp Göteborg, Inst Biomed, Dept Lab Med, Gothenburg, Sweden.,Department of Laboratory Medicine at Institute of Biomedicine, Sahlgrenska Universitety Hospital Göteborg, Göteborg, Sweden

Nodin, Björn (författare): Lund University,Lunds universitet,Terapeutisk patologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Therapeutic pathology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Lund Univ, Dept Clin Sci Lund, Div Oncol & Therapeut Pathol, SE-22100 Lund, Sweden.,Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden

Backman, Max (författare): Uppsala University,Uppsala universitet,Klinisk och experimentell patologi,Patrick Micke,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Lindskog, Cecilia (författare): Uppsala University,Uppsala universitet,Klinisk och experimentell patologi,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Jirström, Karin (författare): Lund University,Lunds universitet,Terapeutisk patologi,Sektion I,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Therapeutic pathology,Section I,Department of Clinical Sciences, Lund,Faculty of Medicine,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Department of Genetics and Pathology, Division of Laboratory Medicine, Region Skåne, Lund, Sweden; Department of Clinical Sciences Lund, Division of Oncology and Therapeutic Pathology, Lund University, Lund, Sweden,Dept Genet & Pathol, Div Lab Med, Lund, Sweden.;Lund Univ, Dept Clin Sci Lund, Div Oncol & Therapeut Pathol, SE-22100 Lund, Sweden.

Mezheyeuski, Artur (författare): Uppsala University,Uppsala universitet,Experimentell och klinisk onkologi,Uppsala Univ, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden.,Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

visa färre...

(creator_code:org_t)

Elsevier, 2021
2021
Engelska.
Ingår i: EBioMedicine. - : Elsevier. - 2352-3964. ; 65

Relaterad länk:: https://doi.org/10.1...; visa fler...; https://uu.diva-port... (primary) (Raw object); http://www.thelancet...; http://dx.doi.org/10... (free); https://umu.diva-por... (primary) (Raw object); https://urn.kb.se/re...; https://doi.org/10.1...; https://lup.lub.lu.s...; http://kipublication...; https://urn.kb.se/re...; visa färre...

Tidskriftsartikel (refereegranskat)

Abstract Ämnesord

Stäng

Background: The development of a reactive tumour stroma is a hallmark of tumour progression and pronounced tumour stroma is generally considered to be associated with clinical aggressiveness. The variability between tumour types regarding stroma fraction, and its prognosis associations, have not been systematically analysed.Methods: Using an objective machine-learning method we quantified the tumour stroma in 16 solid cancer types from 2732 patients, representing retrospective tissue collections of surgically resected primary tumours. Image analysis performed tissue segmentation into stromal and epithelial compartment based on pan-cytokeratin staining and autofluorescence patterns.Findings: The stroma fraction was highly variable within and across the tumour types, with kidney cancer showing the lowest and pancreato-biliary type periampullary cancer showing the highest stroma proportion (median 19% and 73% respectively). Adjusted Cox regression models revealed both positive (pancreato-biliary type periampullary cancer and oestrogen negative breast cancer, HR(95%CI)=0.56(0.34-0.92) and HR (95%CI)=0.41(0.17-0.98) respectively) and negative (intestinal type periampullary cancer, HR(95%CI)=3.59 (1.49-8.62)) associations of the tumour stroma fraction with survival.Interpretation: Our study provides an objective quantification of the tumour stroma fraction across major types of solid cancer. Findings strongly argue against the commonly promoted view of a general associations between high stroma abundance and poor prognosis. The results also suggest that full exploitation of the prognostic potential of tumour stroma requires analyses that go beyond determination of stroma abundance.

Hitta via bibliotek

EBioMedicine (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Cancer och onkol ...

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Klinisk laborato ...

Artiklar i publikationen: EBioMedicine

Av lärosätet: Uppsala universitet; Lunds universitet; Karolinska Institutet; Umeå universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se

The prognostic impact of the tumour stroma fraction : A machine learning-based analysis in 16 human solid tumour types

Ämnesord

Nyckelord

Publikations- och innehållstyp

Hitta via bibliotek

Till lärosätets databas

Hitta mer i SwePub

Sök utanför SwePub